Endotoxemia stimulates many physiologic responses including disturbances in lipid metabolism. We hypothesized that this lipemia may be part of a defensive mechanism by which the body combats the toxic effects of circulating endotoxin. We tested the effects of mixtures of endotoxin, lipoproteins, and lipoprotein-free plasma and determined the ability of varying concentrations of human very low density lipoproteins (VLDL) and chylomicrons, as well as low density lipoproteins (LDL) and high density lipoproteins (HDL), and of the synthetic lipid emulsion SOYACAL to prevent endotoxin-induced death in mice. This study demonstrates that the triglyceride-rich VLDL and chylomicrons, as well as cholesterol-rich LDL and HDL, and cholesterol-free SOYACAL can protect against endotoxin-induced death. Protection required small amounts of lipoprotein-free plasma, and depended on the incubation time and the concentration of lipoprotein lipid. Despite stringent techniques to prevent exogenous endotoxin contamination eight of ten duplicate VLDL preparations contained endotoxin (5,755 +/-3,514 ng endotoxin/mg triglyceride, mean +/-SEM) making the isolation of endotoxin-free VLDL difficult. In contrast, simultaneous preparations of LDL and HDL were relatively free of endotoxin contamination (3 +/-3 and 320 +/-319 ng/mg total cholesterol, respectively), suggesting that the contamination of VLDL occurs in vivo and not during the isolation procedure. These observations suggest a possible role for increased triglyceride-rich lipoproteins in the host's defense against endotoxemia and infection. (VLDL) and chylomicrons, as well as low density lipoproteins (LDL) and high density lipoproteins (HDL), and of the synthetic lipid emulsion SOYACAL to prevent endotoxin-induced death in mice. This study demonstrates that the triglyceride-rich VLDL and chylomicrons, as well as cholesterol-rich LDL and HDL, and cholesterol-free SOYACAL can protect against endotoxin-induced death. Protection required small amounts of lipoprotein-free plasma, and depended on the incubation time and the concentration of lipoprotein lipid. Despite stringent techniques to prevent exogenous endotoxin contamination eight of ten duplicate VLDL preparations contained endotoxin (5,755±3,514 ng endotoxin/mg triglyceride, mean±SEM) making the isolation of endotoxin-free VLDL difficult. In contrast, simultaneous preparations of LDL and HDL were relatively free of endotoxin contamination (3±3 and 320±319 ng/mg total cholesterol, respectively), suggesting that the contamination of VLDL occurs in vivo and not during the isolation procedure. These observations suggest a possible role for increased triglyceride-rich lipoproteins in the host's defense against endotoxemia and infection. (J. Clin. Invest. 1990.
Introduction
Endotoxemia can stimulate a variety of physiologic responses including fever (1), leukocytosis (1) , hypotension (2) , induction of acute-phase reaction proteins (3) , and disturbances in glucose and lipid metabolism (4) (5) (6) (7) . One of the earliest metabolic responses is an increase in plasma very low density lipoprotein (VLDL) levels (8-10), which has been proposed to represent the mobilization of peripheral energy stores to fuel the body's response to the infectious challenge (1 1, 12). However, lipoproteins may function in roles other than the transport of lipid during periods of physiological stress. Some authors have suggested that lipoproteins are directly involved in the host response to infection and tissue destruction (7) . It is possible that the endotoxin-induced hyperlipoproteinemia may represent a physiological defense mechanism wherein the body attempts to combat the toxic effects of circulating endotoxin.
Endotoxin has been shown to interact with cholesterol ester-rich lipoproteins. Ulevitch et al. (13) (14) (15) (16) have elegantly demonstrated the ability of high density lipoproteins (HDL) to bind endotoxin as part of a two-step process requiring serum. Initially serum appears to disaggregate macromolecules of endotoxin. Subsequently, the disaggregated endotoxin binds to HDL as evidenced by a decrease in endotoxin's buoyant density when ultracentrifuged in a CsCl gradient. Once endotoxin is bound to HDL its ability to induce fever, leukocytosis, and hypotension are dramatically reduced (13, 14) . The binding of endotoxin to HDL also prevents endotoxin-induced death in sensitized (adrenalectomized) mice but not in rabbits (13, 17) .
Whereas Ulevitch and co-workers primarily focused on the interaction between HDL and endotoxin, Van Lenten et al. (18) , using New Zealand White rabbits, demonstrated that LDL can also bind endotoxin in much the same way. Endotoxin bound to LDL showed less toxicity to endothelial cells, although it was capable of initiating some components of the inflammatory response (19) .
If endotoxin-induced lipemia, which usually begins with an increase in VLDL, is part of a host defensive response, then the binding of endotoxin by triglyceride (TG)'-rich lipoproteins may be of central importance. Previous studies that have examined this issue showed that the TG-rich VLDL had much less ability to interact and form complexes with endotoxin than did the cholesterol-rich lipoproteins LDL and HDL (14, 18). One study suggested that the reason for this difference may be that a lipoprotein's ability to interact with endotoxin is directly proportional to its cholesterol content (18) . This 20 -fold less than the manufacturer's recommended concentration with endotoxin-free H20 and then incubated in a water bath at 370C for 60 min. Next, 0.4 ml of 0.5 mM chromogenic substrate S-2222 (Helena Laboratories, Beaumont, TX), reconstituted using endotoxin-free PBS, was added, and the mixture was incubated at 370C for an additional 30 min before the reaction was quenched by the addition of 0.4 ml 60% glacial acetic acid. Absorption of the final mixture was measured at 405 nm using a spectrophotometer (Cary model 219, Varian Instrument Co., Sugar Land, TX) with distilled H20 as a zero. The assay was linear over a range of 10-100 pg endotoxin/ml.
Because of the poorly defined interaction between plasma and the Limulus enzymes, the assay of endotoxin in samples containing or derived from plasma has quantitative inaccuracies (21, 25, 26 50% lipoprotein-free plasma had a survival rate of 27% (Fig. 1) . Mice injected with endotoxin in PBS had a survival rate of only 7% (Fig. 1) . When the same dose of endotoxin was incubated with increasing concentrations of VLDL or chylomicrons before injection, mice were increasingly protected from endotoxin-induced death (Fig. 1) . The mice had a survival rate of 100% when the incubation mixture contained at least 10.0 mg of VLDL TG/ml (P < 0.001) or 3.0 mg of chylomicron TG/ml (P < 0.001). Complete protection was also observed when adequate concentrations of LDL (0.5 mg of total cholesterol [TC]/ml, P < 0.001) or HDL (0.05 mg of TC/ml, P < 0.001) were included in the endotoxin-lipoprotein mixture (Fig. 1) .
The finding that TG-rich as well as cholesterol-rich lipoproteins could protect against endotoxin-induced death led us to test whether a nonlipoprotein lipid particle, SOYACAL, could also protect under these conditions. SOYACAL is a lipid emulsion that contains neutral TGs and no cholesterol. The survival rate of mice injected with endotoxin mixtures containing SOYACAL increased with increasing amounts of SOYACAL TG (Fig. 1) , reaching 100% at a concentration of 5.0 mg SOYACAL TG/ml (P . 0.001).
Effect of manipulating the in vitro incubation variables on endotoxin-induced death. Mouse survival increased in parallel with increasing concentrations of lipoprotein-free plasma in the endotoxin-lipoprotein mixture containing SOYACAL or LDL. As the concentration of lipoprotein-free plasma increased from 0 to 2 10%, the survival rate increased from 7% to 100% (Fig. 2) .
Mouse survival increased in parallel with the length oftime the endotoxin-lipoprotein mixture was incubated in 50% lipoprotein-free plasma before intraperitoneal injection (Fig. 3) . Combining the results from both SOYACAL and LDL, the survival rate of the mice was 50% (P = 0.23) when the mixture was injected immediately after mixing, with no incubation time. The survival rate increased to 70% (P < 0.02) after an incubation time of 1 h, and to 100% at 3 h (P < 0.001). Endogenous contamination of native VLDL. We then examined whether lipoproteins collected under conditions carefully designed to prevent exogenous endotoxin contamination contained detectable quantities of endotoxin. To determine the sensitivity of the chloroform extraction technique, we first generated standard curves comparing the detection of endotoxin added to LDL or SOYACAL solutions versus endotoxin added to saline (Fig. 4) . To Fig. 4 ) and a daily standard curve of endotoxin in saline.
Of the 10 VLDL preparations, 8 were contaminated by endotoxin in both duplicate tubes (Table I ). The mean concentration ofendotoxin in VLDL was 5,755±3,514 ng/mg TG (mean±SEM). In contrast, LDL and HDL isolated sequentially by further ultracentrifugation steps from the same plasma rarely had detectable endotoxin, even though these lipoproteins underwent more extensive handling and processing during their isolation than did VLDL. Of the 10 LDL preparations, 3 had low levels of endotoxin, but only in one of the duplicate tubes. Of the eight HDL preparations isolated in duplicate, only two preparations contained detectable endotoxin, again only in one duplicate tube. The mean detectable concentration of endotoxin in VLDL was significantly higher than that found in LDL or HDL (both P < 0.001).
Discussion
Early studies examining the effect of serum on endotoxin were directed at understanding the mechanism by which serum reduced the toxicity of endotoxin (28, 29) . From these studies Skarnes et al. (30) suggested that endotoxin might interact with #-and al-lipoproteins with a resultant modification of endotoxin's physical and immunochemical properties. Subsequently, Ulevitch and Johnston (13) demonstrated that the incubation ofendotoxin with serum, both in vitro and in vivo, reduced its buoyant density and subsequent toxicity. It has been proposed that after incubation with serum, endotoxin is first disaggregated and then binds to HDL to form a stable lipoprotein-endotoxin complex (14). This process is time-, temperature-, and plasma-dependent (16, 29, 31 Interestingly, most studies that have previously examined the ability of VLDL to interact with endotoxin concluded that these TG-rich lipoproteins had minimal endotoxin binding 132  284  36  LDL #1  <1  <1  <1  I  ND  <1  <1  <1  <1  <1  3  3  LDL #2  <1  <1  <1  <1  49  2  <1  <1  <1  <1  HDL #1  ND  <1   5,112   ND  <1  <1  <1  <1  <1  <1  320  319  HDL #2  ND  <1  <1  ND  2  <1  <1  <1 (32) , but potentially play a critical role in the interaction of endotoxins with cell membranes (33) and liposomes (34), the binding of endotoxin to lipoproteins may be dependent on a phospholipid-glycolipid interaction (35, 36) . Manipulation of the in vitro incubation variables showed that neutralization of endotoxin by lipoproteins or SOYACAL was directly dependent on the quantity of lipoprotein-free plasma present in the endotoxin-lipoprotein mixtures and the length of time the mixtures were incubated together before their injection. As in previous studies, lipoprotein-free plasma was required for all lipoproteins to prevent endotoxin-induced death, and a concentration of as low as 10% proved effective. The shortest incubation time that resulted in 100% survival was 3 h. However, there was an increased survival rate after 1 h and a trend towards an increase in the survival rate when there was no incubation time as compared to the control, but this difference failed to reach statistical significance.
Our data also demonstrate that VLDL is frequently contaminated by endotoxin. This finding raises the possibility that previous studies which reported no significant interaction between VLDL and endotoxin may have used VLDL that was contaminated with endotoxin (14, 18). These studies did not detail extensive methods to prevent exogenous endotoxin contamination. Also, their lipoprotein preparations were not assayed for the presence of endotoxin before use. In contrast, in this study we strictly adhered to apyrogenic technique, which required the steam sterilization and dry heating ofall materials used, including stainless steel tubes with custom-crafted silicone O-rings for the isolation of lipoproteins by sequential ultracentrifugation. Because routine steps in the sequential isolation of lipoproteins, including the recovery of supernatants, adjustment of densities, saline dialysis, and storage, represent opportunities for significant exogenous endotoxin contamination, the isolation of endotoxin-free lipoproteins, especially VLDL, required careful attention to detail and technique. Therefore plasma samples were routinely processed in duplicate to assist in identifying potential breaks in apyrogenic technique. Despite these precautions we still found that 80% of the VLDL isolated from 10 healthy volunteers contained detectable levels of endotoxin, averaging 5,755 ng/mg lipoprotein lipid. In contrast, LDL and HDL isolated sequentially from the same plasma samples were almost always free of endotoxin. Theoretically, the detected endotoxin could have been of exogenous origin in spite of our attempts to limit exogenous contamination. But, as illustrated in Table I , when VLDL contained endotoxin, it was uniformly detected in both duplicate samples which is consistent with the endogenous sequestration of endotoxin in vivo. This is in contrast to the pattern of contamination detected in the LDL and HDL samples, where four samples contained endotoxin detectable in only one of the two duplicate tubes. A fifth sample also contained endotoxin but was assayed in a single tube. This pattern of LDL and HDL contamination is compatible with the detection of exogenous endotoxin introduced during the isolation procedure. However, the low levels of contamination in four ofthe five tubes were so near the assay's level ofsensitivity as to allow the possibility that the uncontaminated duplicate tubes actually were contaminated but at a level that could not be detected.
The data reveal that there is a wide variation in the concentrations of detectable endotoxin in the VLDL samples. The variation between samples may be a reflection of the interaction between VLDL and endotoxin in vivo. The contamination of VLDL with endotoxin is presumably the result of incidental endotoxemias which are spontaneous events that could vary in their magnitude.
Because of the frequency with which we found VLDL contamination, it is difficult to accurately estimate how much of this lipoprotein is required to detoxify equivalent amounts of endotoxin. Although numerous VLDL samples were obtained, only those which contained low levels of detectable endotoxin by chloroform extraction (< 100 ng of endotoxin/ mg of VLDL TG) were used to determine VLDL's protective ability. Each The E. coli (055:B5) endotoxin used in this study was derived from a commonly employed, readily available strain of bacteria (37) (38) (39) . Since the endotoxin was isolated via the phenol extraction technique of Westphal et al. (20) , it may have contained some lipid A-associated protein (40), a poten-tially biologically active substance. Although we did not assay for the presence of lipid A-associated protein in our endotoxin preparation, it is possible that endotoxin preparations free of this protein could prove even less toxic than we have demonstrated here. The ability of TG-rich lipid particles to decrease the toxicity of other serotypes and strains of endotoxin warrants further investigation.
The observations that human VLDL and chylomicrons can interact in vitro with endotoxin to prevent its lethal effect in mice, and that human VLDL is frequently contaminated with endotoxin, whereas LDL and HDL are not, may have many potential implications. VLDL, in addition to their role in triglyceride transport, may also function as part of a defensive mechanism to combat the serious pathophysiologic sequellae of endotoxemia. In addition to our results, this theory is supported by the finding that when animals or humans are challenged with infectious agents or endotoxin there are significant changes in the distribution of circulating lipoproteins (4-10, 41, 42) . A consistent early finding is an increase in the concentration of circulating VLDL (8) (9) (10) . This increase in VLDL is now known to be mediated by cytokines, in particular, tumor necrosis factor (43-45). The increase in VLDL could be an attempt by the body to bind and neutralize the toxic effects of any circulating endotoxin. If VLDL functions as part of a defensive mechanism, then the neutralization of endotoxin by circulating TG-rich lipoproteins could help explain why transient endotoxemias, despite their frequency, remain asymptomatic. Daily activities in healthy people, such as tooth brushing and defecating, often introduce endotoxin into the circulation.
In summary, this study shows that VLDL, chylomicrons, and SOYACAL can protect mice against endotoxin-induced death. Since there is little or no cholesterol in these lipid particles, the interaction between endotoxin and lipoproteins does not appear to be determined solely by the lipoproteins' cholesterol content. We, as have others, further show that the interaction between endotoxin and lipoproteins is dependent on a number of in vitro incubation variables. Lastly, the fact that human VLDL is frequently contaminated with endotoxin of probable endogenous origin raises the possibility that increased triglyceride-rich lipoproteins play a role in the host's defense against endotoxemia and infection.
